| poor clinical outcomes associated with a multi-drug resistant clonal strain of pseudomonas aeruginosa in the tasmanian cystic fibrosis population. | clonal strains of pseudomonas aeruginosa have been identified in large cystic fibrosis (cf) centres. whether such strains are more virulent or whether cross-infection between patients explains their widespread prevalence is unknown. this study described the epidemiology of p. aeruginosa infection in cf patients in tasmania, australia, an area with a high cf birth incidence. patients in tasmania are geographically dispersed and when this study was conducted (2003) there was no central cf clinic, ... | 2008 | 18811887 |
| epidemiology of pseudomonas aeruginosa in a tertiary referral teaching hospital. | a genotypically indistinguishable strain of pseudomonas aeruginosa (australian epidemic strain iii: aes iii) has previously been found in a proportion of adults with cystic fibrosis (cf) in tasmania, australia. the aim of this study was to identify a source of these infections within the major tertiary referral hospital for the state of tasmania, and to determine if this strain could be isolated from settings other than the cf lung. a total of 120 isolates of p. aeruginosa were collected from cl ... | 2009 | 19699556 |
| population-based study of cystic fibrosis disease severity and haemochromatosis gene mutations. | haemochromatosis (hfe) mutations increase the risk of bowel obstruction in cystic fibrosis (cf), but the impact on other disease manifestations is unknown. | 2010 | 20199637 |
| virulence gene distribution in clinical, nosocomial and environmental isolates of pseudomonas aeruginosa. | the virulence factor genotypes of a large cohort of clinical, nosocomial environment and community environment isolates (184 in total) of pseudomonas aeruginosa from tasmania, australia, were determined by pcr. the virulence factor genotype of the majority of isolates was highly conserved, with the exception of the virulence gene exou, which demonstrated low prevalence (33 isolates; 18 %) in the population tested. isolates collected from the environment of intensive therapy wards (intensive care ... | 2010 | 20430902 |